Abstract
Surgical principal and objective
Treatment of focal cartilage defects (traumatic or osteochondrosis dissecans) of the talus using a collagen matrix. The goal is to stabilize the superclot formed after microfracturing to accommodate cartilage repair. The procedure can be carried out via miniarthrotomy, without medial malleolus osteotomy.
Indications
International Cartilage Repair Society (ICRS) grade III and IV focal cartilage defects of the talus > 1.5 cm2.
Contraindications
Generalized osteoarthritis, inflammatory joint disease, gout, neuroarthropathy.
Surgical technique
Miniarthrotomy to open the ankle joint. Debridement of unstable cartilage and necrotic bone, curettage of cysts. Filling of the bone defects with autologous cancellous bone. Sealing of reconstructed bone with fibrin glue and attachment of a collagen matrix shaped to precisely fit the defect.
Postoperative regimen
Immobilization for 48 h. Partial weight bearing of 10 kg for 6 weeks, with continuous passive motion. Increasing weight bearing from 7 weeks onwards.
Results
Follow-up of at least 30 months in 14 patients showed improvement in the Score of the American Orthopedic Foot and Ankle Society (AOFAS) from 50 to 89 points, with equal mobility on both sides of the upper ankle joint.
Zusammenfassung
Operationsziel
Therapie von umschriebenen Knorpeldefekten (traumatisch oder durch Osteochondrosis dissecans) des Talus mit einer Kollagenmatrix. Ziel ist es, den Superclot nach der Mikrofrakturierung zu stabilisieren und die Regeneration von Faserknorpel zu unterstützten. Der Eingriff kann über eine Miniarthrotomie ohne Innenknöchelosteotomie durchgeführt werden.
Indikationen
Umschriebene Knorpeldefekte des Talus (Grad III und IV nach International Cartilage Repair Society, ICRS) > 1,5 cm2.
Kontraindikationen
Generalisierte degenerative Gelenkveränderungen, entzündliche Gelenkerkrankung, Gicht, Neuroarthopathie.
Operationstechnik
Eröffnung des Sprunggelenks über eine Miniarthrotomie. Débridement von instabilem Knorpel, nekrotischem Knochen und Zysten. Füllung von Knochendefekten mit autologer Spongiosa. Versiegeln der Spongiosaplastik mit Fibrinkleber und Einkleben einer passgenau zugeschnittenen Kollagenmatrix.
Weiterbehandlung
48 h Ruhigstellung, 6 Wochen Teilbelastung 10 kg und Motorschiene. Ab der 7. Woche stufenweiser Belastungsaufbau.
Ergebnisse
Bei 14 Patienten mit einem Follow-up von mindestens 30 Monaten konnte eine Verbesserung des AOFAS-Scores (American Orthopedic Foot and Ankle Society) von 50 auf 89 Punkte beobachtet werden, bei seitengleicher Beweglichkeit des oberen Sprunggelenks.
Similar content being viewed by others
Introduction
Microfracture is the established procedure for treatment of symptomatic International Cartilage Repair Society (ICRS) grade III–IV cartilage defects of the talus [25]. The purpose of subchondral bone perforation, as in microfracture, is to enhance chondral resurfacing by providing a suitable environment for new tissue formation. The released progenitor cells, mesenchymal stem cells, growth factors and other cytokines form a surgically induced superclot, which provides an enriched environment for fibrous cartilage formation. In defects with subchondral cyst formation, microfracture can be combined with cyst resection and filling of the defect with bone graft from the iliac crest, the tibia or the calcaneus. Compared to all other cartilage repair techniques, the level of evidence for good clinical outcome is highest for microfracture [17]. However, the good initial clinical results are reported to begin to lessen after 5 years [11, 19]. Significantly poorer results have been reported for defects exceeding 1.5 cm2 [4, 5].
Autologous chondrocyte implantation (ACI) has increasing gained popularity for the treatment of larger defects during the past few years. ACI is a procedure in which cartilage cells harvested from the patient are expanded in vitro and then implanted into the joint in a second intervention. The superiority of this expensive and time-consuming cartilage reconstruction technique over that of microfracture could not be conclusively established so far [9, 10, 20]. Current research is focused on one-step procedures, e.g. scaffold-enhanced microfracture, with the goal of providing a simple, cost-effective clinical solution that avoids the problems associated with cell culture and a second surgical intervention [8, 28].
In larger defects, stabilization of the progenitor cell-containing blood clot formed after microfracture presents a problem [18]. By stabilizing this superclot with a biomaterial, the colonization, proliferation and chondrogenesis of mesenchymal stem cells are facilitated [3, 12].
Autologous matrix-induced chondrogenesis (AMIC) is a cartilage repair technique in which, after microfracturing, a collagen type I/III bilayer matrix (Chondro-Gide®, Geistlich Pharma AG, Switzerland) is secured over the cartilage defect using commercially available fibrin glue. Mesenchymal progenitor cells migrate toward and adhere to the porous layer of the matrix; the cell-occlusive compact layer prevents cell loss through leakage into the joint space and protects cells from mechanical stress. In vitro studies have shown that the stability of the collagen matrix form prevents shrinkage of the super clot. Furthermore, its use in combination with fibrin glue (Tissucol or Tisseel from Baxter Healthcare, Deerfield, IL, USA) supports chondrogenic differentiation of human mesenchymal stem cells and significantly enhances proteoglycan deposition [6, 22].
The controversial in vitro evidence on the effects of fibrin glue on mesenchymal stem cells and chondrocytes has been a topic of discussion for well over a decade. In rabbit experiments, Brittberg et al. [2] found that the use of Tisseel impaired healing of osteocondral defects and also reported that no cell migration into Tisseel took place, whereas cell migration was observed into blood clots. In contrast, Homminga et al. [13] have shown that chondrocytes in fibrin glue produce extracellular matrix, retain their typical morphology and divide to form colonies. Nowadays, commercially available fibrin glue is routinely used in orthopedics. It is also standard in matrix-induced autologous chondrocyte implantation (MACI) and no negative results have been reported. Its use is supported by the findings of Sage et al. [23], who stated that fibrin glue increases proliferation of and glycosaminoglycan production by cells in cartilage chips. Kirilak et al. [15] found that fibrin sealant promotes migration and proliferation of human articular chondrocytes and that thrombin, an active component of fibrin glue, stimulates these processes.
Alternative techniques for treatment of focal cartilage defects in the talus are the osteochondral autograft transfer system (OATS), allograft or implantation of in vitro cultured autologous chondrocytes in ACI [1, 14, 24]. The OATS approach is associated with high donor site morbidity. In more than 50 % of cases, complaints in the knee joint from where the grafts were harvested were reported [26]. Furthermore, an autograft cannot be implanted in the ankle without an osteotomy of the medial or lateral malleolus, which can lead to future complications and late adverse effects. Allograft is hardly available in Europe.
Surgical principle and objective
The objective of the procedure is treatment of a talar dome osteochondral lesion (OCL) by microfracture in combination with a collagen matrix. The purpose of the collagen matrix is to retain and stabilize the superclot in the defect zone, as well as to protect it from being displaced [3, 12]. In most cases, the collagen matrix can be implanted without having to perform an osteotomy of the medial or lateral malleolus [29].
Advantages
-
Technically simple surgical procedure
-
Availability of the collagen matrix as a ready-to-use product with long shelf-life (Chondro-Gide®)
-
One-step intervention
-
No donor site morbidity
-
In almost all cases the matrix can be implanted via miniarthrotomy alone, without the need for osteotomy of the lateral or medial malleolus
-
Saves of 90 % of costs compared to cartilage reconstruction with in vitro cultured chondrocytes
Disadvantages
-
Additional costs of the matrix and fibrin glue as compared to microfracture alone
Indications
-
OCL of the talus (ICRS grades III and IV) > 1.5 cm2
-
Osteochondrosis dissecans
-
Instability and axis malalignment do not represent contraindications if these can be addressed along with cartilage reconstruction
Contraindications
-
Generalized degenerative changes in the joint
-
Cartilage defects in the corresponding opposite joint surface
-
Inflammatory joint disease
-
Crystal arthropathy
-
Neuroarthopathy
-
Inferior results in older patients are more likely, although there is no clear age limit for the procedure
Patient information
-
Lower leg in plaster cast for 2 weeks
-
Weeks 1–6: partial weight bearing of 10 kg, continuous passive motion (CPM), physiotherapy
-
Weeks 7–12: step-wise increase in weight bearing (about 20 kg every 2 weeks)
-
Harvesting cancellous bone (calcaneus, head of tibia, pelvic crest)
-
Possible disturbed mobility of ankle with need for surgical revision
-
Possible delayed or absent healing of the cancellous bone graft
-
Possible delayed or absent fibrocartilage formation
-
Possible intolerance to the materials used
-
Possible tendency of swelling for several months
-
Possible wound healing disturbances, sensibility disturbances and/or circulation disorders that can lead to loss of the foot
-
Inability to work: in most cases, working in a sitting position is allowed after 2 weeks and working in a standing position after 12 to 14 weeks. Occupations with greater physical demands can be undertaken within 6 months
-
General risks of surgery
Preoperative workup
-
Clinical assessment of joint stability and hindfoot alignment
-
X-ray of the ankle in two planes. In instances of clinical suspicion of axial malalignment, additional radiographs of the lower leg with the patient standing on one foot and a radiograph of the hindfoot according to Saltzman are recommended
-
MRI of the ankle for assessment of cartilage lesions, possible subchondral cysts, areas of necrotic bone and other accompanying pathologies
-
Documentation of circulation in the foot (posterior tibial and dorsalis pedis artery pulse; if needed, Doppler sonography, capillary refill time)
-
Documentation of sensibility (distinguish between sharp/dull, two-point discrimination)
-
General preparations for surgery. According to guidelines published by the Robert Koch Institute (RKI Guidelines, http://www.rki.de), shaving can be omitted
Instruments and implants
-
Basic set of surgical instruments for ankle surgery
-
Self-retaining Kirschner wire (K-wire) distractor (Fig. 1)
-
Collagen matrix (Chondro-Gide® in different sizes)
-
Fibrin glue (e.g. Tissucol, Baxter Gmbh, Unterschleißheim, Germany)
-
Image intensifier if osteotomy or axial correction is planned
Anesthesia and positioning
-
Intubation, larynx mask, spinal or conduction anesthesia
-
Tourniquet (100 mmHg above the systolic blood pressure) at the upper thigh
-
Radiation protection mat from the head down to the middle of the lower thigh
-
Supine position
Special surgical considerations
-
Depending on the location of the cartilage defect, other approaches can be used to facilitate access to the diseased cartilage area. With a central approach, the entire ankle joint can be well visualized. This approach is particularly useful for treating defects of the medial and lateral talar shoulder, as well as for centrally located defects. The ventrocentral access approach uses the space between the anterior tibial and the extensor hallucis longus tendons (Fig. 10). The neurovascular bundle is retracted laterally using a blunt Hohmann retractor.
-
The ventrolateral approach (Ollier approach) is carried out lateral to the peroneus tertius tendon, ventral to the lateral malleolus (Fig. 11). Lesions of the lateral talar shoulder can be addressed well with this approach. The closure of the capsule can be combined with an external ligaments stabilization procedure.
-
Dorsal approaches are seldom necessary, since with adequate distraction of the joint using the K-wire distractor (Fig. 1), more dorsally located defects can also be accessed. If such an approach is planned, the patient is positioned on the contralateral side in the case of a dorsolateral defect. The affected leg is positioned free, in order to be able to flex the knee to allow for adequate dorsal extension of the ankle joint. The dorsolateral approach runs dorsal to the lateral malleolus and enables medial or lateral retraction of the peroneal tendons (Fig. 12).
-
For a dorsomedial approach between the medial malleolus and the posterior tibial tendon (Fig. 13), the patient is positioned on the affected side. The contralateral leg is well-padded and the affected leg is positioned in a freely moveable manner. The use of a short vacuum mattress considerably facilitates the procedure. Adequate flexion of the knee is necessary to allow free dorsiflexion of the ankle joint.
-
Any axial deformities or instabilities present should be addressed within the context of this intervention. Hindfoot deformity corrections, as well as capsule and ligament reconstructions can be carried out according to standard surgical techniques. Fig. 14 shows a patient with hindfoot varus undergoing a concurrently performed closing wedge osteotomy of the calcaneus.
Postoperative management
-
Complete immobilization of the ankle at 90° for 48 h. If inserted, remove drain after 48 h. Begin with continuous passive motion limited to 20–0–20°, to provide continuous containment of the defect by the tibia during the healing period and to minimize the risk of delamination. In defects located very ventral or dorsal to the joint surface, the recommended range of motion is modified accordingly.
-
Dorsal splint for 2 weeks until wound healing is complete.
-
Weeks 1–6: partial weight bearing of 10 kg.
-
Weeks 7–12: stepwise increase in weight bearing (increasing by 20 kg every 2 weeks).
-
From week 13 onward, daily activities including cycling and swimming are permitted.
-
Sports involving impact load or a rapid change of direction should be avoided for at least 12 months.
-
Whether or not a return to professional sports is possible after cartilage reconstruction has not yet been conclusively established.
-
There is no indication for routine MRI follow-up. However, if the patient complains of persistent pain, MRI is indicated.
Errors, hazards and complications
-
If the OCL cannot be reached adequately, an additional osteotomy should be considered. Ventral access can be extended by a v-shaped osteotomy of the tibial plafond located directly over the lesion. The dorsomedial approach can be enlarged by a medial malleolar osteotomy; the dorsolateral approach by an osteotomy of the fibula.
-
Intraoperative delamination of the matrix can be addressed by elimination of matrix protrusion at the edge of the adjacent cartilage. If the bone graft is too thick, the surface layer should be ablated and the matrix reattached.
-
Deep wound infection should be managed by a wound swab, early surgical debridement and appropriate antibiotic treatment. In the case of joint involvement, repeated joint lavage may be necessary until clinical and systemic infection signs regress.
-
Incomplete healing of bone graft with recurring cyst formation [27]. Repetition of the intervention is possible. However, after failure of initial surgery, it is important to reassess axial malalignment or instability as possible causes.
Results
Postoperative results for a follow-up period of 30 months or more are available for 14 patients with medial talar cartilage defects (ICRS grades III and IV> 1.5 cm2). Patients were treated with AMIC as described (Tab. 1). No intraoperative complications were observed. In 10 cases, a cancellous bone graft from the calcaneus was used. The Score of the American Orthopedic Foot and Ankle Society (AOFAS, based on the score established by Kitaoka [16]) improved from 50.1 ± 9.7 to 89.0 ± 9.3. In 2 patients, MRI revealed new cyst formation. In 1 patient, residual complaints necessitated repeat arthroscopy, which showed an unstable graft and hypertrophic repair tissue with impingement. In all other cases, MRI revealed good defect filling without increased effusion (Fig. 15).
Further sufficiently powered, randomized clinical trials with uniform methodology and validated outcome measures are needed to compare the results of surgical strategies for treating OCLs of the talus. The results suggest that AMIC may be an effective way to treat full-thickness lesions of the talus without harvesting chondrocytes from the talus in patients who do not respond to initial curettage.
References
Adams SB Jr, Viens NA, Easley ME et al (2011) Midterm results of osteochondral lesions of the talar shoulder treated with fresh osteochondral allograft transplantation. J Bone Joint Surg Am 93:648–654
Brittberg M, Sjogren-Jansson E, Lindahl A, Peterson L (1997) Influence of fibrin sealant (Tisseel) on osteochondral defect repair in the rabbit knee. Biomaterials 18:235–242
Chen H, Chevrier A, Hoemann CD et al (2011) Characterization of subchondral bone repair for marrow-stimulated chondral defects and its relationship to articular cartilage resurfacing. Am J Sports Med 39:1731–1740
Choi WJ, Kim BS, Lee JW (2012) Osteochondral lesion of the talus: could age be an indication for arthroscopic treatment? Am J Sports Med 40:419–424
Chuckpaiwong B, Berkson EM, Theodore GH (2008) Microfracture for osteochondral lesions of the ankle: outcome analysis and outcome predictors of 105 cases. Arthroscopy 24:106–112
Dickhut A, Dexheimer V, Martin K et al (2010) Chondrogenesis of human mesenchymal stem cells by local transforming growth factor-beta delivery in a biphasic resorbable carrier. Tissue Eng Part A 16:453–464
Fitzgibbons TC, Hawks MA, McMullen ST, Inda DJ (2011) Bone grafting in surgery about the foot and ankle: indications and techniques. J Am Acad Orthop Surg 19:112–120
Giannini S, Buda R, Vannini F et al (2009) One-step bone marrow-derived cell transplantation in talar osteochondral lesions. Clin Orthop Relat Res 467:3307–3320
Gobbi A (2008) Error in level of evidence. Arthroscopy 24:247
Gobbi A, Francisco RA, Lubowitz JH et al (2006) Osteochondral lesions of the talus: randomized controlled trial comparing chondroplasty, microfracture, and osteochondral autograft transplantation. Arthroscopy 22:1085–1092
Gobbi A, Nunag P, Malinowski K (2005) Treatment of full thickness chondral lesions of the knee with microfracture in a group of athletes. Knee Surg Sports Traumatol Arthrosc 13:213–221
Hoemann CD, Hurtig M, Rossomacha E et al (2005) Chitosan-glycerol phosphate/blood implants improve hyaline cartilage repair in ovine microfracture defects. J Bone Joint Surg Am 87:2671–2686
Homminga GN, Buma P, Koot HW et al (1993) Chondrocyte behavior in fibrin glue in vitro. Acta Orthop Scand 64:441–445
Imhoff AB, Paul J, Ottinger B et al (2011) Osteochondral transplantation of the talus: long-term clinical and magnetic resonance imaging evaluation. Am J Sports Med 39:1487–1493
Kirilak Y, Pavlos NJ, Willers CR et al (2006) Fibrin sealant promotes migration and proliferation of human articular chondrocytes: possible involvement of thrombin and protease-activated receptors. Int J Mol Med 17:551–558
Kitaoka HB, Patzer GL (1997) Analysis of clinical grading scales for the foot and ankle. Foot Ankle Int 18:443–446
Loveday D, Clifton R, Robinson A (2010) Interventions for treating osteochondral defects of the talus in adults. Cochrane Database Syst Rev CD008104
Mithoefer K, McAdams T, Williams RJ et al (2009) Clinical efficacy of the microfracture technique for articular cartilage repair in the knee: an evidence-based systematic analysis. Am J Sports Med 37:2053–2063
Mithoefer K, Scopp JM, Mandelbaum BR (2007) Articular cartilage repair in athletes. Instr Course Lect 56:457–468
Niemeyer P, Salzmann G, Schmal H et al (2011) Autologous chondrocyte implantation for the treatment of chondral and osteochondral defects of the talus: a meta-analysis of available evidence. Knee Surg Sports Traumatol Arthrosc
Raikin SM, Brislin K (2005) Local bone graft harvested from the distal tibia or calcaneus for surgery of the foot and ankle. Foot Ankle Int 26:449–453
Richter W (2009) Mesenchymal stem cells and cartilage in situ regeneration. J Intern Med 266:390–405
Sage A, Chang AA, Schumacher BL et al (2009) Cartilage outgrowth in fibrin scaffolds. Am J Rhinol Allergy 23:486–491
Schneider TE, Karaikudi S (2009) Matrix-Induced Autologous Chondrocyte Implantation (MACI) grafting for osteochondral lesions of the talus. Foot Ankle Int 30:810–814
Steadman JR, Rodkey WG, Briggs KK (2002) Microfracture to treat full-thickness chondral defects: surgical technique, rehabilitation, and outcomes. J Knee Surg 15:170–176
Valderrabano V, Leumann A, Rasch H et al (2009) Knee-to-ankle mosaicplasty for the treatment of osteochondral lesions of the ankle joint. Am J Sports Med 37(Suppl 1):105S–111S
Walther M, Becher C, Volkering C et al (2012) Treatment of chondral and osteochondral defects of the talus by Autologous Matrix Induced Chondrogenesis. Fuß Sprunggelenk 10:121–129
Wiewiorski M, Leumann A, Buettner O et al (2011) Autologous matrix-induced chondrogenesis aided reconstruction of a large focal osteochondral lesion of the talus. Arch Orthop Trauma Surg 131:293–296
Young KW, Deland JT, Lee KT, Lee YK (2010) Medial approaches to osteochondral lesion of the talus without medial malleolar osteotomy. Knee Surg Sports Traumatol Arthrosc 18:634–637
Open Access
This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
Compliance with ethical guidelines
Conflict of interest. Prof. Dr. Markus Walther received reimbursement of travel expenses and speaker’s fees from GeistlichPharma AG, Switzerland. S. Altenberger, S. Kriegelstein, C. Volkering and A. Röser state that there are no conflicts of interest. The accompanying manuscript does not include studies on humans or animals.
Author information
Authors and Affiliations
Corresponding author
Additional information
©The Authors (2014) This article is published with open access at Springerlink.com.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 2.0 International License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Walther, M., Altenberger, S., Kriegelstein, S. et al. Reconstruction of focal cartilage defects in the talus with miniarthrotomy and collagen matrix. Oper Orthop Traumatol 26, 603–610 (2014). https://doi.org/10.1007/s00064-012-0229-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00064-012-0229-9